| 产品描述: | SJ988497 is a PROTAC JAK2 degrader. SJ988497 potently inhibits CRLF2-rearranged (CRLF2r) cell proliferation and degrades the CRBN neosubstrate GSPT1. SJ988497 consists of a Ruxolitinib derivative, linker, and CRBN ligand Pomalidomide. SJ988497 can be used in the research of acute lymphoblastic leukemia (ALL). |
| 体外研究: |
SJ988497 (compound 7) increases cell permeability in the Caco-2 assay, with the apparent permeability coefficient (Papp) of 19.12 nm/s. SJ988497 inhibits parental MHH-CALL-4 cells with an EC50 of 0.4 nM, inhibits CRBN-KD MHH–CALL-4 cells with an EC50 of 3456.2 nM, and can be blocked by 30 μM Lenalidomide.html" class="link-product" target="_blank">Lenalidomide . SJ988497 (1 h, 1 μM) results in comparable JAK inhibition in MHH–CALL-4 cells. |
| 保存条件: |
-20°C |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.452 ml |
7.26 ml |
14.519 ml |
| 5 mM |
0.29 ml |
1.452 ml |
2.904 ml |
| 10 mM |
0.145 ml |
0.726 ml |
1.452 ml |
| 50 mM |
0.029 ml |
0.145 ml |
0.29 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |